They acknowledge that while the technical hurdles of proteomic test development have become manageable, commercialization is still a major challenge.
The company said it would use the funding to continue development of its human microbiome research kits, protocols, and software.
Funded projects will will take advantage of molecular platforms that enable large-scale, robust, and reproducible analysis of transcriptional, epigenomic, proteomic, and metabolomic states.
An international team of researchers analyzed the transcriptomes of post-mortem tissue samples to find transcriptional changes.
WUSTL bioinformatics spinout PierianDx disclosed in an SEC filing that it has raised slightly more than $3 million of a $5 million offering.
OpGen recently launched the first Acuitas test, which is designed to detect the most common bacterial causes of complicated urinary tract infections.
The Regeneron Genetics Center will sequence the full exomes of all DNA samples in the non-profit group's open-access biospecimen repository.
The firm plans to use net proceeds for corporate purposes, including capital expenditures and working capital.
The company's new effort, DigitalMe, has recruited more than 5,000 participants so far, tracking patient health reports alongside genomics and repeat blood biomarker measurements.
Researchers from Rockefeller University sifted through soil microbiomes for genes linked to the function of calcium-dependent antibiotics.
The company has also developed two liquid biopsy cancer test, Liquid GPS Core for DNA and Liquid GPS Expression for RNA.
The proteomics firm is swapping 4 million of its shares for a 10 percent interest in CPR with the goal of moving into clinical trials and related research.
The $649 NGS test screens for 193 disorders, can be ordered online, and is designed to supplement standard state newborn screening services.
Research teams and commercial firms are increasingly using genome editing to address farm animal health and welfare, from viral resistance to physical traits.
During the quarter, the company reopened its CLIA lab in New Haven, Connecticut, following the company's merger with Transgenomic in June.
The firm posted revenues of $530.5 million, with organic growth at 4 percent and acquisitions and currency effects adding 4 percent and 5 percent, respectively.
The US ITC has ruled that Oxford Nanopore's products do not infringe on single-molecule sequencing-related patents held by PacBio.
Clive Brown, the company's chief technology officer, provided an update on the firm's business and talked about new products and planned improvements.
The partnership will allow customers using NEBNext Direct target enrichment products to analyze data with the Bluebee platform.
Using post-mortem data, researchers explored similarities and differences between autism, schizophrenia, bipolar disorder, alcoholism, and depression.
Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.
A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.
In Science this week: CRISPR-based approach for recording cellular events, and more.
A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.